Number of pages: 100 | Report Format: PDF | Published date: July 27, 2022
Historical Years – 2020 | Base Year – 2021 | Forecasted Years – 2022-2030
The global pressure ulcer treatment market was pegged at US$ 3.4 billion in 2021 and is expected to witness a CAGR of 6.84% during the forecast period.
Pressure ulcers are injuries that cause tissue rupture, and skin breakdown. This damage is mostly caused by constant pressure at a particular position, which causes tissue ischemia, termination of nourishment and oxygen which eventually leads to skin mortification. The damage can be relieved by using good-quality beds, mattresses, splints, heel troughs, pillows, etc. Patients with these disorders are mostly observed above the age of 70. Older people are more prone to this problem as they have extreme flexibility and mobility problems that damages the tissue and skin because of dehydration. Obese population is often more confined to beds and chairs and are more likely to catch this problem.
The growing demand for pressure ulcer treatments is owing to the increased number of patients with this disorder, rise in the number of geriatric populations, and patients who underwent surgeries confined to complete rest. However, a lack of proper management from well-trained and skilled professionals, and high cost required for treatments are factors that are able to restrain the growth of the global pressure ulcer treatments market.
The global pressure ulcer treatments market has been analyzed from four perspectives: treatments, wound, end-user, and Region.
Pressure Ulcer Treatments Market By Treatments
On the basis of treatments, this market is classified into wound care devices, wound care therapies, and active therapies. Among these, wound care devices have the highest stake in the market. The factors attributed to the leading position of this segment are perpetual technological advancements resulting in innovative products with better effectiveness, and high investments in research and development of such devices. There are many devices introduced with new advanced inventions that can provide information such as temperature, moisture content, sensors for movements of the body, and the amount of pressure applied to the wound. New innovations will continue to improve the number of devices for the treatment of pressure ulcers. These devices may offer major advancements such as reducing the risk of ulcer progression and making life easy for the patients.
Proper treatments for pressure ulcers are necessary, as they can lead to massive chronic diseases like cancer. Advanced dressings with silver sulfadiazine and nitrofurazone are recommended for treatments in such conditions. Debridement treatments are given when the contaminated or dead tissue is removed from the infected area through surgical procedures. This treatment provides a rapid granulation of tissue. The skin graft treatments repair the shallow defects and pressure injuries. Skin graft treatment is of two types split-thickness and full-thickness grafts. Split-thickness treatments are used to treat shallow defects, but the only disadvantage of these treatments is skin barriers which are problematic in the treatments. Patients with deeper tissue loss are recommended with full-thickness grafts, it requires entire excision of the skin.
Pressure Ulcer Treatments Market by Wound Type
Based on wounds, the market is grouped into Stage 1, Stage 2, Stage 3, and Stage 4 this classification is according to the National Pressure Ulcers Advisory Panel (NPUAP). Stage 1 includes when the ulcers are not yet broken down into the skin, Stage 2 includes when the ulcers have broken the top two layers of skin, the epidermis and dermis. Stage 3 includes when ulcers are affecting the top two layers of skin and the fatty tissue i.e. the adipose tissue. Stage 4 is when the sores are now a proper deep wound which can impact the other muscles, tissues, tendons, and ligaments. Stage 1 ulcers are the area that appears red and warm in touch., whereas stage 2 ulcers are more severe, patients take this condition seriously in stage 2 ulcers as pain and inflammation occur at this point.
Pressure Ulcer Treatments Market by Region
Regionally, the global pressure ulcer treatments market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America has the highest stake in the global pressure ulcer treatments market, owing to factors such as a rise in the geriatric population, increased technological advancement, expansion of healthcare sectors, and high demand for new innovative devices. For instance, NF Health Care's medical devices reduce the risk of sores and ulcers by reducing stress on various pressure points on the patient's body when lying down for extended periods of time. The devices provide a static support surface that distributes the pressure generated by the body's contact with the surface, lowering the risk of pressure ulcers. The company's proprietary technology consists of an innovative viscos-elastic polymer gel encased in natural latex. Europe has the next leading market section; the credit for this goes to factors such as the high incidence of chronic disorders. Asia Pacific is also going to see significant growth in this market because of new technological advancements, as well as growing awareness, increased incidence, improved healthcare expenditure, and evolution of healthcare infrastructure.
Some of the prominent players operating in the global pressure ulcer treatments market are
Mölnlycke Health Care AB announced the acquisition of M&J Airlaid Products A/S in January 2019. (M&J). M&J was a private Danish company that produces specialized and high-quality absorbent Airlaid nonwoven materials. Mölnlycke's wound care products rely on M&J's Airlaid technology, as well as foams and soft silicone.
Growing demand for pressure ulcer treatments is owing to the increased number of patients with this disorder, the rise in the number of geriatric populations, and patients who underwent surgeries requiring prolonged rest.
Some of the prominent players operating in the pressure ulcer treatment market are Smith & Nephew plc, Hill Rom Holdings Inc., Cardinal Health, Acelity L.P Inc., B. Braun Melsungen AG, 3M Company, ConvaTech group plc, Coloplast Group plc., Integra Lifesciences, ArjoHuntleigh, and Talley Group Limited among others.
The market is expected to witness a CAGR of 6.84 % during the forecast period.
However, a lack of proper management due to dearth of knowledge or skilled professionals, and the high cost required for the treatments are factors that are able to restrain the growth of the global pressure ulcer treatments market.
*Insights on financial performance is subject to availability of information in public domain